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ABSTRACT: An indium-mediated isomerization of 1,4-
dienols to 1,3-dienols is described. This procedure consists
of the addition of pentadienylindium, in a protic solvent, to
aldehydes giving the kinetic γ-allylation product in high yields.
The subsequent conversion of this γ-allylation product to its
thermodynamic 1,3-dienol α-isomer can be achieved by its
exposure to indium triﬂate in the presence of a substoichiometric amount of aldehyde at room temperature. This transformation
exhibited moderate to good substrate scope and has been shown to proceed by a 2-oxonia Cope rearrangement.
■ INTRODUCTION
1,4-Dienol motifs (1) are a valuable and sought after
precursors in organic synthesis because of their unique
functional connectivity. 1,4-Dienols 1 can undergo elimination
reactions to give trienes such as 2 that have been shown to be
excellent Diels−Alder platforms (Scheme 1), therefore
enabling signiﬁcant molecular complexity to be built up
quickly in very few synthetic transformations.1 The con-
nectivity of 1,4-dienols (1) has been harnessed in ruthenium-
catalyzed RCM transformation delivering unique cyclic and
polycyclic structures.2 Furthermore, 1,4-dienol 1 can undergo
facile isomerization to the thermodynamically favored α-allylic
alcohol product 3 (1,3-dienol) that is central to numerous
natural products of biological importance as well as useful
synthetic intermediates (Scheme 1).3
The resolvin D- and E-series (Scheme 2, e.g., resolving D1
and resolving E1) are a class of metabolites derived from ω-3
fatty acids, docosahexaenoic acid, and eicosapentaenoic acid.
They have been implicated in the regulation of human diseases
linked to chronic inﬂammation such as cardiovascular diseases,
asthma, and rheumatoid arthritis.4a−c In a project looking at
the biological importance of these fatty acids metabolites,4d we
required access to a range of racemic 1,3-dienols with aryl,
alkenyl, and alkynyl substitution that mirrored that within the
resolvin D1 and E1 structures (Scheme 2, 4−6). We envisaged
that 1,3-dienols of this type could be accessed via a 2-oxonia
Cope rearrangement of a 1,4-dienol, which in turn could be
accessed from an appropriate aldehyde (9) and a pentadienyl
equivalent (Scheme 2). This approach was based on two
benchmarks (a) the ability to easily synthesize the 1,4-dienol
precursors and (b) literature precedent for the thermodynamic
rearrangement to the required 1,3-dienols.
First, in the literature, there are several robust synthetic
methods for the synthesis of 1,4-dienol precursors (10), all of
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which are based on the addition of a pentadienyl equivalent to
carbonyl substrate 9 (Scheme 2). These include the Lewis
acid-mediated addition of 2,4-pentadienyltrimethylsilane5−7
and pentadienyltrimethylstannane8 to an aldehyde. Pentadie-
nylzincates9 and penta-2,4-dienyltitanium complexes10 have
also been successfully added to carbonyls, and the direct
addition of a 1,4-pentadienyl equivalent via treatment with a
strong base11 has also been successfully employed. An alternate
and more environmentally applicable approach has been the
addition of pentadienylindium, generated from an indium
metal and pentadienylbromide, to the requisite carbonyl.
Indium has become an important metal in Barbier-type
additions to carbonyls because of its functional group tolerance
and low toxicity.12,13 Second, the 2-oxonia Cope rearrange-
ments are not unprecedented when performed on 1,4-dienols
(Scheme 2); Nokami3a and co-workers demonstrated that 1,4-
dienol 7 undergoes a diastereoselective, acid catalyzed, 2-
oxonia Cope rearrangement to give its α-product 8, in high
enantiomeric excess; however, this report was limited to only
three aliphatic examples. Therefore, we would like to disclose
our results on using this 2-oxonia Cope rearrangement to
synthesize 1,3-dienols with aryl, alkenyl, and alkynyl sub-
stitutions.
■ RESULTS AND DISCUSSION
The target compounds for our study necessitated the selection
of aldehyde 12 as the starting point. Previous reports had
already indicated that DMF, THF, and DMSO would be ideal
solvents for the addition of bromide 13, as they all gave the
required γ-addition product. However, in a desire to use more
environmentally benign solvents, H2O was selected as the
starting point, previously used only by Fallis within the context
of bromide 13 and a small subset of aldehydes and ketones.1f,3b
Consequently, when aldehyde 12 was exposed to 13, indium
(1.5 equiv), and H2O, it was gratifying to isolate the desired γ-
addition product 14 in 51% isolated yield (Scheme 3). This
modest yield and signiﬁcant amount of the unreacted starting
material in the crude 1H NMR led us to question the solubility
of starting material 12 in H2O as the solvent. To address this a
3:1 mixture of ethanol14 and water was trialed, leading to a
welcome increased isolated yield of 67%, conﬁrming our
speculation. Finally, a further increase in isolated yield to 81%
was obtained when absolute ethanol was used.
With optimized conditions in hand, we then examined these
conditions on aryl, alkenyl, and alkynyl aldehydes that were
appropriate for our study (Scheme 4).
Benzaldehyde and 2-, 3-, and 4-bromobenzaldehyde gave the
expected 1,4-dieneol products (15−18) in good to excellent
yields of 71−92%; however, p-anisaldehyde yielded its addition
product 19 in a very poor isolated yield of only 5%, due likely
to the deactivation of the electrophile by the methoxy group.
An increase in steric bulk was accommodated as indicated by
the successful conversion of α-naphthaldehyde giving its
addition product 20 in 86% isolated yield. Acetophenone
also underwent smooth addition to give the γ-addition product
21a in 76%; however, within the crude 1H NMR, a small trace
amount of the α-addition product 22b could be identiﬁed,
possibly due to the increase in steric bulk of the electrophile.
Cinnamaldehyde gave its addition product 22 in 60% isolated
yield, and both linear and branched aliphatic aldehydes gave
the desired 1,4-dienols in good to high yields giving 23 and 24
in 76 and 69% yields, respectively. The alkynyl aldehyde 12,
crucial to our own work,4d could also be scaled up to 12 mmol,
giving the addition product 14 in an isolated yield of 80%. We
also found that glycoaldehyde dimer 26 could be utilized in
this process giving access to the diol 25 in 72% isolated yield.
The isomerization of 1,4-dienols to the desired 1,3-dienols
was optimized using substrate 15 (Scheme 5 and Table 1).
Initially, we found that simple heating of 15 did not yield the
desired 1,3-dienol but simply returned the starting material
(entries 1 and 2). We then investigated the use of a Lewis acid
catalyst to eﬀect the rearrangement of 15 to 27 and found that
In(OTf)3,
15a Sn(OTf)2, and AlCl3, all at room temperature,
Scheme 3. Indium-Mediated Addition of Bromide 13 to
Aldehyde 12 in H2O, Ethanol, and Mixtures Thereof
Scheme 4. Synthesis of 1,4-Dienols
Scheme 5. Optimization Experiments for the Conversion of
1,4-Dienol 15 to Its Respective Conjugated Species 27
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achieved the rearrangement, but in poor isolated yields (entries
3−5).16 It must be noted that 27 was isolated in a E/Z ratio of
approx. 9:1, in favor of the E-stereoisomer, in each case. With
these promising results in hand, we next examined the addition
of benzaldehyde in an eﬀort to promote the 2-oxonia Cope
rearrangement.3a,15b,c Accordingly, upon the addition of 10
mol % of benzaldehyde, in the presence of In(OTf)3, we
isolated the desired 1,3-diene-ol 27 in a dramatically improved
yield of 67% (entry 6). A screen in the amount of
benzaldehyde was then examined, but no discernible increase
in isolated yields was observed (entries 7−9). A control
experiment in the absence of Lewis acid, but in the presence of
10 mol % of benzaldehyde, conﬁrmed the crucial role of the
Lewis acid in this rearrangement (entry 10). An increase in the
reaction temperature had no signiﬁcant eﬀect on the isolated
product yield of 27 (entry 11), and when this elevated
temperature attempt was performed in the absence of
benzaldehyde (entry 12), the result mirrored that in entry 3.
Finally, extending the reaction time had no noticeable eﬀect in
the isolated yield of 27 (entry 13).
With conditions for the 2-oxonia Cope rearrangement of
1,4-dienol 15 to 27 now identiﬁed, the scope of this reaction
process was examined using 1,4-dienols from Scheme 4
(Scheme 6).
This process was met with moderate success. The 2-, 3-, and
4-bromoaryl analogues were all rearranged to the target 1,3-
diene-ol in good isolated yields giving 28, 29, and 30,
respectively. The α-naphthyl analogue participated in the
rearrangement giving the thermodynamic product 32 in good
yield, and the rearrangement was tolerant of alkyl substitution
as exempliﬁed by the cyclohexyl 34 and isovaleryl 35 examples.
The aryl 1,4-diene 15 could be rearranged at an increased scale
of 5 mmol giving the 1,3-diene 27 in comparable chemical
yield. Finally, the TMS protected alkynyl-1,4-diene 14 was
converted to its 1,3-diene isomer 36 in a good yield, and
pleasingly, this gave a valuable building block that could be
potentially used in further work toward the synthesis of the
resolvins and other marine-derived fatty acids. Unfortunately,
the 4-methoxyaryl (19), pent-4-en-2-ol (21a), cinnammyl
(22), and 1,2-diol 25 precursors gave little or none of the
desired products (31, 33, 21b, and 37, respectively), as well as
yielding complex mixtures of products as identiﬁed by NMR in
each case. With regard to the E/Z stereoisomer ratio, the
majority of the aryl derivatives were obtained in a ratio in-line
with the parent phenyl analogue, that is, E/Z ratio of approx.
9:1. However, the 2-bromophenyl derivative, 28, was obtained
as the E-isomer exclusively, with none of its Z-isomer observed
in the 1H NMR spectra. In contrast, the cyclohexyl (34) and
isovaleryl (35) analogues were obtained in E/Z ratios of 3:2
and 3:1, respectively.
The 1,3-dienol 37 derived from 1,2-diol 25 would have
contained a useful synthetic handle; however, its failure to
participate in the rearrangement could be mitigated as shown
below in Scheme 7. Treatment of 15 with ethyl propiolate gave
the enol ester 38, which when treated with TFA gave
thermodynamic diene 39 in 82% in an E/Z ratio of 94:6 and
with a 1,3-diene with a useful synthetic handle for further
manipulation.
Mechanistically, the 2-oxonia Cope rearrangement follows
the reports previously published (Scheme 8).3,15 First, Lewis
acid activation of benzaldehyde promotes the formation of the
oxocarbenium ion 41 via 40. This oxocarbenium ion 41 then
undergoes a 2-oxonia Cope rearrangement to deliver the
thermodynamic product 42, with none of the Prins cyclization
product 43 being detected or isolated. It is assumed15,17 that
the 2-oxonia Cope rearrangement goes via the corresponding
chair transition states. The dominant stereoisomer in each
rearrangement was of E-stereochemistry; however, in some
cases, a small amount of the Z-stereoisomer could be detected
by 1H NMR spectroscopy, and this presumably occurs via
Table 1. Optimization Experiments for the Conversion of
1,4-Dienol 15 to Its Respective Conjugated Species 27a
entry Lewis acidb benzaldehyde (mol %) temp. (°C) yield 27 [%]c
1 − − rt −
2 − − 40 −
3 In(OTf)3 − rt 23
4 AlCl3 − rt 22
5 Sn(OTf)2 − rt 23
6 In(OTf)3 10 rt 67
7 In(OTf)3 20 rt 65
8 In(OTf)3 50 rt 67
9 In(OTf)3 100 rt 67
10 − 10 rt −
11 In(OTf)3 10 40 63
12 In(OTf)3 − 40 19
13d In(OTf)3 10 rt 66
aReactions were performed in CH2Cl2 under N2 atmosphere at 0.5 M
for 24 h unless otherwise stated. b10 mol % of Lewis acid. cIsolated
yields in all cases. d48 h reaction time.
Scheme 6. Synthesis of 1,3-Dienols
Scheme 7. Acid-Catalyzed Rearrangement of 1,2-Diol 38
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bond rotation between C2−C3 within 41 as shown by 41a and
41aa (Scheme 8).
■ CONCLUSIONS
In summary, we have reported a two-step process for the
synthesis of 1,3-dienols. A 2-oxonia Cope rearrangement was
utilized to rearrange 1,4-dienols to their thermodynamic 1,3-
dienol products, and this was facilitated by Lewis acid catalysis
with a substoichiometric amount of the requisite aldehyde.
This process has modest substrate scope but unfortunately
failed with cinnamyl-substituted systems. However, it was
demonstrated to be tolerant of alkynes, which in the context of
our research programme should provide a suitable synthetic
building for synthesizing fatty acid analogues.
■ EXPERIMENTAL PROCEDURES
General Procedure for Indium Addition with (E)-5-
Bromopenta-1,3-diene. Aldehyde or ketone (1.00 mmol)
and (E)-5-bromopenta-1,3-diene 13 (1.20 mmol) were added
to absolute ethanol (6 mL) and allowed to stir at room
temperature. Indium powder (1.50 mmol) was added slowly,
so as not to increase the temperature of the reaction mixture,
and then allowed to stir at room temperature for 72 h. The
reaction mixture was diluted with diethyl ether and then
ﬁltered through a plug of silica. The solvent was then removed
by evaporation under reduced pressure, and the crude product
was puriﬁed by column chromatography.
1-Phenyl-2-vinylbut-3-en-1-ol (15).8d The title compound
was isolated by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.4) yielding a colorless liquid (157 mg, 0.90
mmol, 92%): 1H NMR (CDCl3, 400 MHz): δ 7.41−7.28 (m,
5H), 5.88 (ddd, J = 17.2, 10.4, 8.2 Hz, 1H), 5.71 (ddd, J =
17.2, 10.4, 7.2 Hz, 1H), 5.26 (dt, J = 9.6, 0.8 Hz, 1H), 5.22 (dt,
J = 16.0, 1.2 Hz, 1H), 5.07 (dt, J = 10.4, 1.2 Hz, 1H), 5.04 (dt,
J = 17.2, 1.2 Hz, 1H), 4.61 (dd, J = 6.8, 2.0 Hz, 1H), 3.13 (dq,
J = 7.2, 0.8 Hz, 1H), 2.27 (br s, 1H); 13C NMR (CDCl3, 100
MHz): δ 140.8, 135.8, 135.7, 127.1, 126.9, 125.7, 117.4, 116.1,
75.2, 55.2; IR (NaCl): 3079, 3066, 1634, 1603 cm−1; HRMS
(ESI): m/z [M + H]+ calcd for C12H14O, 175.1123; found,
175.1126.
1-(2-Bromophenyl)-2-vinylbut-3-en-1-ol (16). The title
compound was isolated by column chromatography (4:1,
light petroleum/ethyl acetate, Rf = 0.4) yielding a colorless
liquid (225 mg, 0.89 mmol, 89%): 1H NMR (CDCl3, 400
MHz): δ 7.50 (dd, J = 8.0, 1.2 Hz, 1H), 7.46 (d, J = 7.6 Hz,
1H), 7.31 (t, J = 15.2 Hz, 1H), 7.11 (dt, J = 7.6, 2.0 Hz, 1H),
5.95−5.83 (m, 2H), 5.21−5.01 (m, 5H), 3.20 (q, J = 6.8 Hz,
1H), 2.25 (s, 1H); 13C NMR (CDCl3, 100 MHz): δ 141.1,
137.1, 135.6, 132.7, 128.9, 129.6, 127.7, 122.6, 118.6, 117.0,
74.5, 54.5; IR (NaCl): 3427, 3077, 1636, 619 cm−1; HRMS
(ESI): m/z [M + H]+ calcd for C12H12O
79Br, 251.0066; found,
251.0068.
1-(3-Bromophenyl)-2-vinylbut-3-en-1-ol (17). The title
compound was isolated by column chromatography (4:1,
light petroleum/ethyl acetate, Rf = 0.4) yielding a colorless
liquid (180 mg, 0.71 mmol, 71%): 1H NMR (CDCl3, 400
MHz): δ 7.51−7.49 (m, 1H), 7.41 (dt, J = 6.8, 2.0 Hz, 1H),
7.26−7.19 (m, 2H), 5.83 (ddd, J = 17.2, 10.4, 8.0 Hz, 1H),
5.69 (ddd, J = 17.6, 10.4, 7.2 Hz, 1H), 5.27 (ddd, J = 10.4, 1.6,
0.8 Hz, 1H), 5.18 (dd, J = 17.2, 1.6, 0.8 Hz, 1H), 5.10 (dt, J =
10.4, 1.2 Hz, 1H), 5.04 (dt, J = 17.2, 1.2 Hz, 1H), 4.56 (d, J =
6.8 Hz, 1H), 3.07 (q, J = 7.2 Hz, 1H), 2.40 (br s, 1H); 13C
NMR (CDCl3, 100 MHz): δ 144.2, 136.3, 136.2, 130.7, 129.9,
129.7, 125.6, 118.8, 117.6, 122.3, 75.5, 56.2; IR (NaCl): 3400,
3084, 1637, 739 cm−1; HRMS (ESI): m/z [M + H]+ calcd for
C12H12O
79Br, 251.0066; found, 251.0058.
1-(4-Bromophenyl)-2-vinylbut-3-en-1-ol (18).1a The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.4) yielding a colorless liquid
(228 mg, 0.90 mmol, 90%): 1H NMR (CDCl3, 400 MHz): δ
7.44 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 5.80 (ddd, J
= 18.0, 10.8, 8.4 Hz, 1H), 5.64 (ddd, J = 17.6, 10.8, 7.2 Hz,
1H), 5.25−5.13 (m, 2H), 5.07−4.97 (m, 2H), 4.54 (dd, J =
7.2, 3.2 Hz, 1H), 3.03 (q, J = 7.6 Hz, 1H), 2.24 (d, J = 3.2 Hz,
1H); 13C NMR (CDCl3, 100 MHz): δ 140.8, 136.4, 136.3,
131.2, 128.6, 121.5, 118.8, 117.6, 75.5, 56.3; IR (NaCl): 3420,
3079, 1635, 623 cm−1; HRMS (ESI): m/z [M + H]+ calcd for
C12H12O
79Br, 251.0066; found, 251.0068.
1-(4-Methoxyphenyl)-2-vinylbut-3-en-1-ol (19).9b The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.3) yielding a dark yellow liquid
(11 mg, 0.05 mmol, 5%): 1H NMR (CDCl3, 400 MHz): δ 7.22
(d, J = 8.0 Hz, 2H), 6.86 (d, J = 7.6 Hz, 2H), 5.84 (dt, J = 16.8,
9.2 Hz, 1H), 5.64 (dt, J = 16.8, 8.0 Hz, 1H), 5.21 (dd, J = 16.4,
10.0 Hz, 2H), 5.01 (t, J = 10.4 Hz, 2H), 4.52 (d, J = 7.2 Hz,
1H), 3.79 (s, 3H), 3.07 (q, J = 7.6 Hz, 1H), 2.16 (br s, 1H);
13C NMR (CDCl3, 100 MHz): δ 159.1, 137.1, 136.8, 134.0,
128.1, 118.3, 117.0, 113.6 (×2), 75.8, 56.3, 55.3; IR (NaCl):
3419 (br), 1634, 1219 cm−1; HRMS (ESI): m/z [M + Na]+
calcd for C13H16O, 227.1048; found, 227.1037.
1(1-Naphthyl)-2-vinylbut-3-en-1-ol (20). The title com-
pound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.4) yielding a colorless liquid
(192 mg, 0.86 mmol, 86%): 1H NMR (CDCl3, 400 MHz): δ
8.08 (d, J = 8.0 Hz, 1H), 7.86 (d, J = 8.0 Hz, 1H), 7.78 (d, J =
8.0 Hz, 1H), 7.60 (d, J = 7.2 Hz, 1H), 7.53−7.45 (m, 4H),
5.96−5.81 (m, 2H), 5.45 (dd, J = 6.0, 3.6 Hz, 1H), 5.22 (dd, J
= 10.4, 0.8 Hz, 1H), 5.12−5.03 (m, 3H), 3.41−3.38 (m, 1H),
2.22 (d, J = 3.6 Hz, 1H); 13C NMR (CDCl3, 100 MHz): δ
137.8, 137.6, 136.3, 133.9, 130.7, 129.1, 128.2, 126.1, 125.5,
125.3, 124.5, 123.3, 118.6, 116.8, 72.9, 54.8; IR (NaCl): 3583,
3084, 1677, 1421, 1265 cm−1; HRMS (ESI): m/z [M + Na]+
calcd for C16H16O, 247.1099; found, 247.1083.
2-Phenylpent-4-en-2-ol (21a).8d The title compound was
isolated by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.4) yielding a colorless liquid (142 mg, 0.76
mmol, 76%): 1H NMR (CDCl3, 400 MHz): δ 7.44−7.41 (m,
2H), 7.38−7.33 (m, 2H), 7.28−7.24 (m, 1H), 5.81 (ddd, J =
17.2, 10.4, 8.8 Hz, 1H), 5.74 (ddd, J = 17.6, 10.4, 7.2 Hz, 1H),
Scheme 8. Mechanism for the Kinetic to Thermodynamic
Isomerization Using In(OTf)3
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5.20 (ddd, J = 10.4, 1.6, 0.4 Hz, 1H), 5.16−5.13 (m, 1H),
5.14−5.09 (m, 2H), 3.15 (t, J = 7.6 Hz, 1H), 2.17 (s, 1H), 1.57
(s, 3H); 13C NMR (CDCl3, 100 MHz): δ 146.4, 136.8, 136.3,
127.9, 126.7, 125.5, 118.1, 75.3, 29.8, 27.6; HRMS (ESI): m/z
[M + Na]+ calcd for C13H16O, 211.1099; found, 211.1087.
1-(Cinnamyl)-2-vinylbut-3-en-1-ol (22).6b The title com-
pound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.3) yielding a dark yellow liquid
(120 mg, 0.60 mmol, 60%): 1H NMR (CDCl3, 400 MHz): δ
7.46−7.41 (m, 2H), 7.38−7.34 (m, 2H), 7.31−7.26 (m, 1H),
6.65 (dd, J = 16.0, 0.8 Hz, 1H), 6.27 (dd, J = 16.0, 6.4 Hz,
1H), 5.97−5.88 (m, 1H), 5.92−5.86 (m, 1H), 5.29−5.19 (m,
4H), 4.30 (t, J = 6.0 Hz, 1H), 3.08−3.02 (tq, J = 7.2, 1.2 Hz,
1H), 2.12 (br s, 1H); 13C NMR (CDCl3, 100 MHz): δ 136.8,
136.6, 131.6, 129.7, 128.6, 127.7, 126.6, 118.0, 117.7, 76.8,
55.0; IR (NaCl): 3400, 3061, 1636 cm−1; HRMS (ESI): m/z
[M + H]+ calcd for C14H16O, 201.1279; found, 201.1273.
1-Cyclohexyl-2-vinylbut-3-en-1-ol (23).8d The title com-
pound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.5) yielding a colorless liquid
(137 mg, 0.76 mmol, 76%): 1H NMR (CDCl3, 400 MHz): δ
5.85 (ddd, J = 16.4, 10.0, 8.4 Hz, 1H), 5.85−5.77 (m, 1H),
5.17 (dd, J = 10.0, 1.6 Hz, 1H), 5.12 (ddd, J = 10.8, 2.0, 1.2
Hz, 1H), 5.12−5.10 (m, 1H), 5.09−5.07 (m, 1H), 3.29−3.25
(m, 1H), 2.95 (q, J = 7.2 Hz, 1H), 1.88−1.79 (m, 1H), 1.78−
1.69 (m, 2H), 1.68−1.57 (m, 2H), 1.48−1.37 (m, 1H), 1.29−
1.00 (m, 5H); 13C NMR (CDCl3, 100 MHz): δ 136.5, 135.3,
115.4, 114.2, 75.3, 49.7, 38.4, 27.9, 24.9, 24.5, 24.4, 24.2; IR
(NaCl): 3435 (br), 3077, 1633 cm−1; HRMS (ESI): m/z [M +
Na]+ calcd for C12H20O, 203.1412; found, 203.1406.
6-Methyl-3-vinylhept-1-en-4-ol (24).18 The title compound
was isolated by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.4) yielding a colorless liquid (106 mg, 0.69
mmol, 69%): 1H NMR (CDCl3, 400 MHz): δ 5.86 (ddd, J =
10.0, 8.0, 4.8 Hz, 1H), 5.81 (ddd, J = 12.8, 7.6, 4.4 Hz, 1H),
5.21 (dd, J = 10.4, 1.2 Hz, 1H), 5.18−5.15 (m, 1H), 5.16−5.14
(m, 1H), 5.13 (ddd, J = 5.6, 2.4, 0.8 Hz, 1H), 3.65 (dt, J = 9.6,
4.4 Hz, 1H), 2.79 (q, J = 7.6 Hz, 1H), 1.89−1.79 (m, 1H),
1.65 (d, J = 4.4 Hz, 1H), 1.36−1.29 (m, 2H), 0.95 (d, J = 6.8
Hz, 3H), 0.92 (d, J = 6.4 Hz, 3H); 13C NMR (CDCl3, 100
MHz): δ 137.6, 136.9, 117.6, 116.9, 71.2, 55.4, 43.4, 24.6, 23.8,
21.7; IR (NaCl): 3368 (br), 3079, 1635 cm−1; HRMS (ESI):
m/z [M + H]+ calcd for C10H18O, 155.1436; found, 155.1429.
3-Vinylpent-4-ene-1,2-diol (25). The title compound was
isolated by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.2) yielding a colorless oil (92 mg, 0.72
mmol, 72%): 1H NMR (CDCl3, 400 MHz): δ 5.86 (ddd, J =
16.8, 10.8, 8.0 Hz, 1H), 5.77 (ddd, J = 16.8, 10.8, 8.0 Hz, 1H),
5.21−5.16 (m, 2H), 5.15−5.11 (m, 2H), 3.71−3.62 (m, 2H),
3.55−3.47 (m, 1H), 3.23 (br s, 1H), 3.15 (m, 1H), 2.88 (q, J =
8.0 Hz, 1H); 13C NMR (CDCl3, 100 MHz): δ 136.8, 136.7,
117.5, 117.1, 73.6, 64.6, 51.7; IR (NaCl): 3365 (br), 3003,
1637 cm−1; HRMS (ESI): m/z [M + Na]+ calcd for C7H12O2,
151.0735; found, 151.0729.
1-(Trimethylsilyl)-4-vinylhex-5-en-1-yn-3-ol (14). Alde-
hyde 12 (1.51 g, 12.00 mmol) and (E)-5-bromopenta-1,3-
diene 13 (2.12 g, 14.40 mmol) were added to absolute ethanol
(20 mL) and allowed to stir at room temperature. Indium
powder (2.05 g, 18.00 mmol) was added in portions, so as not
to increase the temperature of the reaction mixture and then
allowed to stir at room temperature for 72 h. The reaction
mixture was diluted with diethyl ether and then ﬁltered
through a plug of silica. The solvent was then removed by
evaporation under reduced pressure, and the crude product
was puriﬁed by column chromatography. The title compound
was isolated by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.6) yielding a pale yellow oil (1.87 g, 9.60
mmol, 80%): 1H NMR (CDCl3, 400 MHz): δ 5.91 (ddd, J =
17.2, 10.4, 8.0 Hz, 2H), 5.28−5.18 (m, 4H), 4.33 (dd, J = 7.2,
5.6 Hz, 1H), 3.07−3.02 (m, 1H), 2.10 (d, J = 7.2 Hz, 1H),
0.19 (s, 9H); 13C NMR (CDCl3, 100 MHz): δ 136.1, 135.7,
118.7, 118.2, 104.6, 91.2, 65.3, 54.7, 0.01; IR (NaCl): 3429
(br), 3008, 2173, 1638 cm−1; HRMS (ESI): m/z [M + Na]+
calcd for C11H18OSi, 217.1019; found, 217.1020.
General Procedure for the Rearrangement from
Branched to Straight Chain Diene. Branched chain diene
(1.0 mmol) in dichloromethane (2.0 mL/mmol) was added to
indium triﬂuoromethanesulfonate (10 mol %) and the
aldehyde (10 mol %) and allowed to stir at room temperature
for 24 h. The reaction mixture was then transferred to a
separating funnel, diluted with further dichloromethane, and
washed with distilled water. The organic extracts were retained,
dried (Na2SO4), and ﬁltered, and the solvent was removed by
evaporation under reduced pressure. The title compound was
isolated by column chromatography. The following com-
pounds were synthesized using this method.
(E)-1-Phenylhexa-3,5-dien-1-ol (27). The title compound
was isolated by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.3) yielding a colorless liquid (116 mg, 0.67
mmol, 67%): 1H NMR (400 MHz, CDCl3): δ 7.42−7.29 (m,
5H), 6.35 (td, J = 16.8, 10.0 Hz, 1H), 6.22 (dd, J = 15.2, 10.4
Hz, 1H), 5.71 (dt, J = 15.2, 7.2 Hz, 1H), 5.18 (d, J = 16.4 Hz,
1H), 5.06 (d, J = 10.0 Hz, 1H), 4.80−4.74 (m, 1H), 2.60−2.56
(m, 2H), 2.13 (d, J = 3.2 Hz, 1H); 13C NMR (100 MHz,
CDCl3): δ 143.9, 136.8, 134.4, 130.1, 128.5, 127.7, 125.8,
116.3, 73.7, 42.6; IR (NaCl): 3411, 3080, 3030, 1634, 1603
cm−1; HRMS (ESI): m/z [M − H+] calcd for C12H13O,
173.0966; found, 173.0961.
(E)-1-(2-Bromophenyl)hexa-3,5-dien-1-ol (28). The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.3) yielding a colorless liquid
182 mg, 0.72 mmol, 71%): 1H NMR (400 MHz, CDCl3): δ
7.82 (d, J = 7.6 Hz, 1H), 7.64 (dd, J = 8.0, 1.2 Hz, 1H), 7.18−
7.08 (m, 2H), 6.07 (d, J = 1.2 Hz, 1H), 5.95−5.84 (m, 1H),
5.71 (dd, J = 16.0, 5.6 Hz, 1H), 5.29 (dd, J = 5.6, 2.4 Hz, 1H),
4.58 (dd, J = 10.8, 5.6 Hz, 1H), 2.64−2.53 (m, 1H), 2.39−2.28
(m, 1H); 13C NMR (100 MHz, CDCl3): δ 142.7, 133.1, 132.7,
132.6, 130.5, 128.5, 121.2, 100.6, 78.0, 77.2, 72.1, 40.6; IR
(NaCl): 3428, 3077, 1636, 619 cm−1; HRMS (ESI): m/z [M
− H+] calcd for C12H12O79Br, 251.0072; found, 251.0065.
(E)-1-(3-Bromophenyl)hexa-3,5-dien-1-ol (29). The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.3) yielding a colorless liquid
(175 mg, 0.69 mmol, 69%): 1H NMR (400 MHz, CDCl3): δ
7.57−7.54 (m, 1H), 7.45−7.41 (m, 1H), 7.31−7.22 (m, 2H),
6.34 (td, J = 16.8, 10.0 Hz, 1H), 6.20 (dd, J = 15.2, 10.4 Hz,
1H), 5.68 (dt, J = 15.2, 7.6 Hz, 1H), 5.19 (d, J = 16.8 Hz, 1H),
5.08 (d, J = 10.0 Hz, 1H), 4.75−4.71 (m, 1H), 2.59−2.46 (m,
2H), 2.11 (d, J = 3.2 Hz, 1H); 13C NMR (100 MHz, CDCl3):
δ 146.2, 136.6, 134.9, 132.8, 130.6, 130.0, 129.4, 124.4, 122.6,
116.7, 72.9, 42.7; IR (NaCl): 3391, 3084, 1637, 704 cm−1;
HRMS (ESI): m/z [M − H+] calcd for C12H12O79Br,
251.0072; found, 251.0059.
(E)-1-(4-Bromophenyl)hexa-3,5-dien-1-ol (30). The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.3) yielding a colorless liquid
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(180 mg, 0.71 mmol, 72%): 1H NMR (400 MHz, CDCl3): δ
7.46 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 6.30 (td, J =
16.8, 10.8 Hz, 1H), 6.15 (dd, J = 15.6, 10.4 Hz, 1H), 5.63 (dt, J
= 14.4, 8.0 Hz, 1H), 5.15 (dd, J = 16.8, 7.6 Hz, 1H), 5.07−5.01
(m, 1H), 4.74−4.66 (m, 1H), 2.55−2.43 (m, 2H), 2.00 (d, J =
3.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): δ 142.8.136.6,
134.9, 131.6, 129.4, 127.6 (×2), 121.4, 116.6, 70.0, 42.7; IR
(NaCl): 3419, 3079, 1635, 623 cm−1; HRMS (ESI): m/z [M
− H+] calcd for C12H12O79Br, 251.0072; found, 251.0066.
(E)-1-(1-Naphthyl)hexa-3,5-dien-1-ol (14) (32). The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.3) yielding a colorless liquid
(152 mg, 0.68 mmol, 72%): 1H NMR (400 MHz, CDCl3): δ
8.06 (d, J = 8.8 Hz, 1H), 7.88−7.86 (m, 1H), 7.78 (d, J = 7.6
Hz, 1H), 7.66 (d, J = 7.2 Hz, 1H), 7.65−7.46 (m, 3H), 6.34
(dt, J = 16.8, 10.4 Hz, 1H), 6.22 (dd, J = 14.8, 10.4 Hz, 1H),
5.81 (pent, J = 7.6 Hz, 1H), 5.52 (dd, J = 8.4, 3.2 Hz, 1H),
5.19−5.16 (m, 1H), 5.08−5.04 (m, 1H), 2.84−2.75 (m, 1H),
2.66−2.59 (m, 1H), 2.13 (br s, 1H); 13C NMR (100 MHz,
CDCl3): δ 139.5, 136.8, 134.4, 133.9, 130.5, 130.3, 129.1,
128.1, 126.2, 125.6, 125.6, 123.0, 122.9, 116.4, 70.5, 41.8;
HRMS (ESI) m/z [M + Na+] calcd for C16H16O, 247.1099;
found, 247.1083.
(E)-1-Cyclohexylhexa-3,5-dien-1-ol (34). The title com-
pound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.4) yielding a colorless liquid
(108 mg, 0.60 mmol, 60%): 1H NMR (400 MHz, CDCl3): δ
6.31 (td, J = 17.2, 10.4 Hz, 1H), 6.18−6.08 (m, 1H), 5.70 (q, J
= 8.0 Hz, 1H), 5.11 (d, J = 16.4 Hz, 2H), 3.42−3.34 (m, 1H),
2.38−2.29 (m, 2H), 2.22−2.13 (m, 1H), 1.40−0.98 (m, 10H);
13C NMR (100 MHz, CDCl3): δ 136.9, 134.0, 131.3, 115.8,
75.3, 41.4, 29.9, 29.7, 26.6, 26.4, 26.3, 22.7; IR (NaCl): 3457,
3088, 2928, 1650 cm−1; HRMS (ESI) m/z [M − H+] calcd for
C12H19O, 179.1436; found, 179.1429.
(E)-1-Isovalerylhexa-3,5-dien-1-ol (35). The title com-
pound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.4) yielding a colorless liquid
(97 mg, 0.63 mmol, 63%): 1H NMR (400 MHz, CDCl3): δ
6.31 (dt, J = 16.8, 10.4 Hz, 1H), 6.12 (dd, J = 15.2, 10.8 Hz,
1H), 5.70 (pent, J = 7.6 Hz, 1H), 5.13 (d, J = 12.4 Hz, 1H),
5.00 (dd, J = 8.8, 1.2 Hz, 1H), 3.72−3.68 (m, 1H), 2.36−2.25
(m, 1H), 2.19−2.11 (m, 1H), 1.86−1.72 (m, 1H), 1.49 (br s,
1H), 1.42−1.36 (m, 1H), 1.27−1.19 (m, 1H), 0.91−0.88 (m,
6H); 13C NMR (100 MHz, CDCl3): δ 136.9, 134.3, 130.7,
116.0, 69.2, 46.2, 41.3, 24.7, 26.5, 22.1; IR (NaCl): 3584, 3086,
2927, 1651, 1467, 1367, 1004 cm−1; HRMS (ESI) m/z [M +
Na+] calcd for C10H18O, 177.1255; found, 177.1241.
(E)-1-(Trimethylsilyl)octa-5,7-dien-1-yn-3-ol (36). The title
compound was isolated by column chromatography (4:1, light
petroleum/ethyl acetate, Rf = 0.5) yielding a pale yellow liquid
(110 mg, 0.53 mmol, 53%): 1H NMR (400 MHz, CDCl3): δ
6.37 (td, J = 16.8, 10.8 Hz, 1H), 6.26−6.19 (m, 1H), 5.77 (td,
J = 14.8, 7.6 Hz, 1H), 5.19 (dd, J = 16.8, 0.8 Hz, 1H), 5.09
(dd, J = 10.4, 1.2 Hz, 1H), 4.43 (q, J = 6.0 Hz, 1H), 2.52 (t, J =
6.4 Hz, 2H), 0.18 (s, 9H); 13C NMR (100 MHz, CDCl3): δ
137.0, 135.0, 128.5, 116.5, 105.9, 90.0, 62.2, 40.9, 0.1; IR
(NaCl): 3400, 2999, 2152, 1618 cm−1; HRMS (ESI) m/z [M
+ H+] calcd for C11H18OSi, 195.1205; found, 195.1200.
Ethyl (E)-3-([1-Phenyl-2-vinylbut-3-en-1-yl]oxy)acrylate
(38). To a solution of diene 15 (192 mg, 1.10 mmol), THF
(3.00 mL) was added DABCO (12 mg, 0.10 mmol) and the
resulting solution was stirred under N2 and cooled to 0 °C. To
this was added ethyl propiolate (0.10 mL, 1.00 mmol) drop
wise over 5 min and the reaction mixture then allowed to warm
to room temperature and stirred overnight. The reaction
mixture was then concentrated in vacuo, and the resultant oil
was puriﬁed by column chromatography (4:1, light petroleum/
ethyl acetate, Rf = 0.8) yielding a colorless liquid (284 mg, 0.95
mmol, 95%): 1H NMR (CDCl3, 400 MHz): δ 7.48 (d, J = 12.8
Hz, 1H), 7.35−7.25 (m, 3H), 7.22−7.18 (m, 2H), 5.80 (ddd, J
= 17.2, 10.4, 7.6 Hz, 1H), 5.69 (ddd, J = 17.2, 10.0, 7.2 Hz,
1H), 5.18 (d, J = 12.4 Hz, 1H), 5.15−5.04 (m, 2H), 5.05−4.98
(m, 2H), 4.83 (d, J = 6.0 Hz, 1H), 4.14−4.09 (m, 2H), 3.24−
3.18 (m, 1H), 1.20 (t, J = 6.8 Hz, 3H); 13C NMR (CDCl3, 100
MHz): δ 167.8, 161.5, 137.6, 136.0, 135.6, 128.4, 128.3, 127.0,
118.0, 117.7, 98.7, 86.4, 59.8, 54.2, 14.4; IR (NaCl): 3584,
2981, 1731, 1651, 1373 cm−1; HRMS (ESI): m/z [M + Na]+
calcd for C17H20O3, 295.1310; found, 295.1293.
Ethyl (E)-3-Hydroxyocta-5,7-dienoate (39). To a solution
of 38 (100 mg, 0.37 mmol) in CH2Cl2 (2.00 mL) under a N2
atmosphere at 0 °C was added TFA (0.03 mL, 0.41 mmol),
and the resultant reaction mixture was allowed to warm to
room temperature and stirred overnight. After this period,
NaHCO3 (2 mL) was added to the reaction mixture, the
reaction mixture was then transferred to a separating funnel
with additional CH2Cl2 (20 mL) and water (20 mL), the layers
separated, and the aqueous layer extracted with a further
portion of CH2Cl2 (20 mL). The combined organic extracts
were then dried (Na2SO4) and ﬁltered, and the solvent was
removed under vacuum and the crude oil was puriﬁed by
column chromatography (4:1, light petroleum/ethyl acetate, Rf
= 0.3) yielding a colorless liquid (56 mg, 0.30 mmol, 82%): 1H
NMR (CDCl3, 400 MHz): δ 6.30 (dt, J = 16.8, 10.4 Hz, 1H),
6.12 (dd, J = 15.2, 10.8 Hz, 1H), 5.69 (pent, J = 7.2 Hz, 1H),
5.12 (d, J = 16.8 Hz, 1H), 5.00 (d, J = 9.6 Hz, 1H), 4.15 (q, J =
7.6 Hz, 1H), 4.11−4.04 (m, 1H), 2.98 (d, J = 3.6 Hz, 1H),
2.50 (dd, J = 16.8, 4.0 Hz, 1H), 2.40 (dd, J = 16.4, 8.8 Hz,
1H), 2.36−2.23 (m, 2H), 1.25 (t, J = 7.2 Hz, 3H); 13C NMR
(CDCl3, 100 MHz): δ 171.9, 136.8, 134.3, 129.7, 116.3, 67.7,
60.8, 40.7, 39.7, 14.3; IR (NaCl): 3583, 2983, 2253, 1719,
1374 cm−1; HRMS (ESI): m/z [M + Na]+ calcd for C10H16O3,
207.0997; found, 207.0983.
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Kocǒvsky,́ P. Enantioselective and catalytic methods for α-crotylation
of aldehydes with a kinetic self-refinement of stereochemistry.
Chem.Eur. J. 2009, 15, 1570−1573.
(16) The rearranged product observed in entries 3-5 and 12 can
conceivably be explained by a Lewis acid catalyzed retro-ene process,
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